---
figid: PMC4885545__cej-25-65-g004
figtitle: Luteolin (Lut) modulates the Raf/PI3K signaling pathway in KRAS and BRAF
  mutated cancer cells and HER2-overexpressing cancer cells
organisms:
- Allium cepa
- Daucus carota
- Capsicum annuum
- Petroselinum crispum
- Apium graveolens Dulce Group
- Perilla frutescens
- Limoniastrum guyonianum
- Helichrysum pamphylicum
- Mus musculus
- Rattus norvegicus
- Gallus gallus
- Opsanus beta
- Homo sapiens
- Canis lupus familiaris
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4885545
filename: cej-25-65-g004.jpg
figlink: /pmc/articles/PMC4885545/figure/F4/
number: F4
caption: Luteolin (Lut) modulates the Raf/PI3K signaling pathway in KRAS and BRAF
  mutated cancer cells and HER2-overexpressing cancer cells. Luteolin inhibits Ras’s
  downstream client proteins and PI3K signaling pathways. Luteolin noncompetitively
  binds with ATP to abolish Raf activity and competitively binds with ATP to inhibit
  PI3K activity. However, p21 induction by luteolin could confer on cancer cells a
  survival advantage by activating mTOR signaling. mTOR, mammalian target of rapamycin.
papertitle: Molecular targets of luteolin in cancer.
reftext: Muobarak J. Tuorkey. Eur J Cancer Prev. 2016 Jan;25(1):65-76.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9701477
figid_alias: PMC4885545__F4
figtype: Figure
redirect_from: /figures/PMC4885545__F4
ndex: 94da515d-deaf-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4885545__cej-25-65-g004.html
  '@type': Dataset
  description: Luteolin (Lut) modulates the Raf/PI3K signaling pathway in KRAS and
    BRAF mutated cancer cells and HER2-overexpressing cancer cells. Luteolin inhibits
    Ras’s downstream client proteins and PI3K signaling pathways. Luteolin noncompetitively
    binds with ATP to abolish Raf activity and competitively binds with ATP to inhibit
    PI3K activity. However, p21 induction by luteolin could confer on cancer cells
    a survival advantage by activating mTOR signaling. mTOR, mammalian target of rapamycin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Erbb2
  - rs
  - ras
  - Hras
  - Kras
  - Rem1
  - Pik3r1
  - Zhx2
  - Akt1
  - Mdk
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Ephb2
  - Mapk1
  - Mtor
  - ERBB2
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ATP8A2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - ATPsynbeta
  - Atpalpha
  - Raf
  - Akt
  - Dsor1
  - Mtk
  - dap
  - Erk7
  - rl
  - Tor
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
